Efficacy, Safety, and Patient Satisfaction of Patient-Controlled Remimazolam Sedation in Outpatient Colonoscopy: A randomized controlled trial.

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525809-13-00

Enrollment

Registered

2026-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

therefore the trial is not concerned with the underlaying medical condition leading to the colonoscopy., The trial will study sedation related to colonoscopy

Brief summary

Composit outcome consisting of four parameters: procedure succes, no moderate/severe adverse events, discharge whitout delay and high patient satisfaction

Interventions

DRUGMIDAZOLAM

DRUGALFENTANIL

DRUGREMIMAZOLAM

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Composit outcome consisting of four parameters: procedure succes, no moderate/severe adverse events, discharge whitout delay and high patient satisfaction	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 7, 2026